Chongqing Zhifei Biological Products Co., Ltd. (SHE: 300122)
China
· Delayed Price · Currency is CNY
32.09
-2.64 (-7.60%)
Oct 11, 2024, 11:13 AM CST
Chongqing Zhifei Biological Products Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 46,614 | 52,914 | 38,260 | 30,629 | 15,156 | 10,525 | Upgrade
|
Other Revenue | 117.18 | 4.08 | 3.85 | 23.46 | 34.23 | 61.91 | Upgrade
|
Revenue | 46,731 | 52,918 | 38,264 | 30,652 | 15,190 | 10,587 | Upgrade
|
Revenue Growth (YoY) | 5.36% | 38.30% | 24.83% | 101.79% | 43.48% | 102.50% | Upgrade
|
Cost of Revenue | 35,117 | 38,997 | 25,518 | 15,728 | 9,316 | 6,154 | Upgrade
|
Gross Profit | 11,614 | 13,921 | 12,746 | 14,925 | 5,875 | 4,433 | Upgrade
|
Selling, General & Admin | 3,105 | 3,155 | 2,595 | 2,121 | 1,410 | 1,278 | Upgrade
|
Research & Development | 992.94 | 968.47 | 854.16 | 552.63 | 299.65 | 169.55 | Upgrade
|
Other Operating Expenses | 235.21 | 238.75 | 177.02 | 135.23 | 70.99 | 51.41 | Upgrade
|
Operating Expenses | 4,768 | 4,715 | 4,047 | 3,000 | 1,863 | 1,567 | Upgrade
|
Operating Income | 6,846 | 9,206 | 8,698 | 11,924 | 4,011 | 2,866 | Upgrade
|
Interest Expense | -90.56 | -81 | -53.3 | -56.14 | -127.14 | -76.11 | Upgrade
|
Interest & Investment Income | 84.09 | 67.94 | 46.09 | 61.47 | 11.98 | 10.85 | Upgrade
|
Currency Exchange Gain (Loss) | -1.74 | 2.28 | 15.4 | -10.1 | 3.84 | 1.91 | Upgrade
|
Other Non Operating Income (Expenses) | -29.77 | -36.56 | -22.64 | -17.23 | -19.61 | -11.46 | Upgrade
|
EBT Excluding Unusual Items | 6,808 | 9,159 | 8,684 | 11,902 | 3,880 | 2,791 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | -5.63 | -13.33 | -1.07 | Upgrade
|
Gain (Loss) on Sale of Assets | -1.72 | 41.37 | 0.01 | 0.04 | -0 | 0 | Upgrade
|
Asset Writedown | -0.24 | -0.13 | -0.09 | -1.68 | -0.55 | -0.73 | Upgrade
|
Other Unusual Items | 147.06 | 142.34 | 34.31 | 35.83 | -12.34 | -23.93 | Upgrade
|
Pretax Income | 6,953 | 9,342 | 8,718 | 11,931 | 3,854 | 2,765 | Upgrade
|
Income Tax Expense | 908.4 | 1,272 | 1,179 | 1,723 | 552.75 | 398.94 | Upgrade
|
Net Income | 6,044 | 8,070 | 7,539 | 10,209 | 3,301 | 2,366 | Upgrade
|
Net Income to Common | 6,044 | 8,070 | 7,539 | 10,209 | 3,301 | 2,366 | Upgrade
|
Net Income Growth | -25.10% | 7.04% | -26.15% | 209.23% | 39.51% | 63.05% | Upgrade
|
Shares Outstanding (Basic) | 2,398 | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 | Upgrade
|
Shares Outstanding (Diluted) | 2,398 | 2,400 | 2,400 | 2,400 | 2,400 | 2,400 | Upgrade
|
Shares Change (YoY) | -0.06% | -0.00% | 0.00% | -0.00% | 0.00% | -0.00% | Upgrade
|
EPS (Basic) | 2.52 | 3.36 | 3.14 | 4.25 | 1.38 | 0.99 | Upgrade
|
EPS (Diluted) | 2.52 | 3.36 | 3.14 | 4.25 | 1.38 | 0.99 | Upgrade
|
EPS Growth | -25.05% | 7.04% | -26.15% | 209.23% | 39.50% | 63.06% | Upgrade
|
Free Cash Flow | 5,500 | 7,862 | 535.93 | 6,575 | 2,670 | 794.06 | Upgrade
|
Free Cash Flow Per Share | 2.29 | 3.28 | 0.22 | 2.74 | 1.11 | 0.33 | Upgrade
|
Dividend Per Share | 0.800 | 0.800 | 0.333 | 0.400 | 0.333 | 0.333 | Upgrade
|
Dividend Growth | 140.02% | 140.02% | -16.68% | 20.01% | 0% | 0% | Upgrade
|
Gross Margin | 24.85% | 26.31% | 33.31% | 48.69% | 38.67% | 41.87% | Upgrade
|
Operating Margin | 14.65% | 17.40% | 22.73% | 38.90% | 26.41% | 27.07% | Upgrade
|
Profit Margin | 12.93% | 15.25% | 19.70% | 33.30% | 21.73% | 22.35% | Upgrade
|
Free Cash Flow Margin | 11.77% | 14.86% | 1.40% | 21.45% | 17.57% | 7.50% | Upgrade
|
EBITDA | 7,187 | 9,515 | 9,003 | 12,297 | 4,132 | 2,954 | Upgrade
|
EBITDA Margin | 15.38% | 17.98% | 23.53% | 40.12% | 27.20% | 27.91% | Upgrade
|
D&A For EBITDA | 341.13 | 308.87 | 304.88 | 372.24 | 120.93 | 88.51 | Upgrade
|
EBIT | 6,846 | 9,206 | 8,698 | 11,924 | 4,011 | 2,866 | Upgrade
|
EBIT Margin | 14.65% | 17.40% | 22.73% | 38.90% | 26.41% | 27.07% | Upgrade
|
Effective Tax Rate | 13.07% | 13.62% | 13.52% | 14.44% | 14.34% | 14.43% | Upgrade
|
Revenue as Reported | 46,731 | 52,918 | 38,264 | 30,652 | 15,190 | 10,587 | Upgrade
|
Advertising Expenses | - | 475.81 | 395.05 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.